IPO registrations (S-1, F-1) · Registrants
INSMED Inc
- SEC CIK
- 1104506 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-09-25, last 2000-10-24; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2000-10-27
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- VA
- Business address
- 700 US HIGHWAY 202/206, Bridgewater, NJ 08807
- EIN
- 54-1972729
- Ticker
- INSM (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- INSMED Inc on the corporate pages
Offering terms
- Final price
- $11.88 per share (424B4 filed 2000-10-27)
- Shares sold
- 6,500,000 (5,500,000 by the company, 1,000,000 by selling holders)
- Gross proceeds
- $77,187,500 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol INSM
- Lead underwriters
- Robertson Stephens
- Syndicate
- BofA Securities; Prudential Securities; Prudential-Bache International Limited (1,625,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INSMED INCORPORATED EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Insmed Incorporated Fuzzy (name and state)
- Business registration: Insmed Incorporated Fuzzy (name and state)
- Business registration: Insmed Incorporated Fuzzy (name and state)
- Business registration: Insmed Incorporated Fuzzy (name and state)
- Business registration: INSMED INCORPORATED Fuzzy (name and state)
- Business registration: INSMED INCORPORATED Fuzzy (name and state)
- Business registration: INSMED INCORPORATED Fuzzy (name and state)
- Business registration: INSMED INCORPORATED Fuzzy (name and state)
- Form 5500 plan sponsor: INSMED INCORPRATED EXACT (EIN (EXACT))
- Federal award recipient: INSMED INCORPORATED Fuzzy (name and state)
- Lobbying client: INSMED, INC. Fuzzy (name and state)
- Lobbying client: INSMED INCORPORATED Fuzzy (name and state)
- Lobbying client: INSMED INCORPORATED Fuzzy (name and state)
- SEC filer: INSMED Inc EXACT (CIK (EXACT))
- Person page: Kenneth G Condon Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-09-25 | S-1 | S-1 (registration) | INSMED INC | 0000916641-00-001379 ↗ |
| 2000-10-24 | S-1/A | S-1/A (amendment) | INSMED INC | 0000916641-00-001511 ↗ |
| 2000-10-27 | 424B4 | 424B4 (final prospectus) | INSMED INC | 0000916641-00-001534 ↗ |
| 2000-10-27 | S-1MEF | S-1MEF (added securities) | INSMED INC | 0000950109-00-004238 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-10-24 | S-1/A | registration statement | 6,000,000 | - | Nasdaq INSM | 7 | primary document; shares headline, underwriting table 4, cover names 3 | document ↗ | ||
| 2000-10-27 | 424B4 | final prospectus | $11.88 | 6,500,000 | $77,187,500 | Nasdaq INSM | 4 | primary document; price table, shares headline, proceeds table, underwriting table 1, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Keuer Thomas A | Officer | Senior VP, Operations (sub) | 1 | 2006 | |
| Young Philip J | Officer | CBO and EVP, Commercial Ops | 2 | 2006–2007 | |
| TULLY KEVIN P | Officer | Executive VP and CFO; Executive VP & CFO; Executive VP & CFO | 6 | 2006–2011 | |
| CONDON KENNETH G | Director | 6 | 2006–2010 | person page Fuzzy | |
| CROOKE GRAHAM K | Director | 7 | 2006–2010 | ||
| ENGELSEN STEINAR J | Director | 28 | 2006–2021 | ||
| SHAROKY MELVIN MD | Director | 57 | 2006–2026 | ||
| WHITCOMB RANDALL W | Director | 16 | 2006–2015 | ||
| Farrar Doug | Officer | Sr. VP of Pharmaceutical Op.; Vice President, ITP; Vice President, Manufacturing | 5 | 2006–2009 | |
| GUNN RONALD D | Officer | Executive VP and COO | 1 | 2007 | |
| ALLAN GEOFFREY | Director,Officer | President, CEO and Chairman | 3 | 2007–2009 | |
| Glover Steve C | Officer | President Follow-on Biologics; President Follow-On Biologics | 4 | 2007–2009 | |
| Lanfear Dennis M | Director | 6 | 2007–2010 | ||
| Kelley Glen L | Officer | VP, REGULATORY AFFAIRS | 1 | 2009 | |
| LaBella Nicholas A. Jr. | Officer | Chief Scientific Officer | 3 | 2010–2011 | |
| GUPTA RENU | Officer | Chief Medical Officer; EVP & Chief Medical Officer; EVP of Development & CMO; Executive Vice President & CMO | 9 | 2010–2014 | |
| HAYDEN DONALD J JR | Director | 20 | 2010–2019 | ||
| Whitten Timothy | Director,Officer; Officer | President & CEO | 5 | 2010–2012 | |
| Gurreri Nicholas Lee | Officer; Other | Senior VP, Commercial Ops | 2 | 2010–2011 | |
| Kollender Richard S | Director | 6 | 2011–2013 | ||
| Drucker Andrea Holtzman | Officer | Senior V.P., General Counsel; SVP, Gen. Counsel & Corp Sec. | 3 | 2011–2013 | |
| ALTOMARI ALFRED | Director | 19 | 2012–2024 | ||
| Lewis William | Director,Officer; Officer | Chair and CEO; Chair & CEO; Chair&Chief Executive Officer; Chairman and CEO; Chairman, President & CEO; President and CEO; President & CEO | 96 | 2012–2026 | |
| ACM Capital Partners, LLC | TenPercentOwner | 1 | 2012 | ||
| Ayer Capital Management, LP | TenPercentOwner | 1 | 2012 | ||
| Ayer Capital Partners, LLC | TenPercentOwner | 1 | 2012 | ||
| Venkatesan Jay | TenPercentOwner | 1 | 2012 | ||
| FMR LLC | TenPercentOwnerOther | 10 | 2012–2013 | ||
| Drechsler Andrew T | Officer | Chief Financial Officer | 13 | 2012–2017 | |
| Pauls Matthew | Officer | Chief Commercial Officer | 5 | 2013–2014 | |
| Pellizzari Christine A | Officer | Chief Legal Officer; General Counsel & Corp. Sec.; General Counsel & Secretary | 24 | 2013–2021 | |
| MCGIRR DAVID W J | Director | 17 | 2013–2026 | ||
| Brennan David R | Director | 19 | 2014–2026 | ||
| Berry Peggy | Officer | Vice President, Regulatory | 5 | 2014–2015 | |
| Quigley Mark | Officer | Vice President, Quality | 4 | 2014–2015 | |
| Schaeffer Orlov S Nicole | Officer | Chief People Strategy Officer; SVP, HR & Corp. Svcs. | 54 | 2014–2026 | |
| POTTER MYRTLE S | Director | 8 | 2014–2018 | ||
| SULLIVAN EUGENE JEFFREY | Officer | Chief Medical Officer; Chief Med. & Scientific Ofc. | 7 | 2015–2017 | |
| Adsett Roger | Officer | Chief Commercial Officer; Chief Operating Officer | 46 | 2016–2026 | |
| TOMBESI PAOLO | Officer | Chief Financial Officer | 4 | 2017–2019 | |
| STRECK PAUL | Officer | Chief Medical Officer | 4 | 2017–2018 | |
| LEE LEO | Director | 13 | 2018–2026 | ||
| SORIANO JOHN | Officer | Chief Compliance Officer | 12 | 2018–2021 | |
| ANDERSON ELIZABETH M | Director | 12 | 2018–2026 | ||
| GOLL JOHN | Officer | Chief Accounting Officer; Chief Act. Off. & Controller | 4 | 2019–2020 | |
| Desjardins Clarissa | Director | 10 | 2019–2026 | ||
| Flammer Martina M.D. | Officer | Chief Medical Officer | 48 | 2019–2026 | |
| Bonstein Sara | Officer | Chief Financial Officer | 34 | 2020–2026 | |
| SCHAFER CAROL | Director | 9 | 2020–2026 | ||
| Smith Michael Alexander | Officer | Chief Legal Officer; General Counsel, Senior VP | 39 | 2021–2026 | |
| Wise John Drayton | Officer | Chief Commercial Officer | 15 | 2022–2025 | |
| Butera Samuele | Officer | SVP, GM, Global Respiratory | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | INSMED INCORPORATED | NJ | State business registries | EIN (EXACT, as the state registration reports it) |
| SEC filer | INSMED Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Insmed Incorporated | State business registries | name and state | |
| Business registration | Insmed Incorporated | State business registries | name and state | |
| Business registration | Insmed Incorporated | State business registries | name and state | |
| Business registration | Insmed Incorporated | State business registries | name and state | |
| Business registration | INSMED INCORPORATED | State business registries | name and state | |
| Business registration | INSMED INCORPORATED | State business registries | name and state | |
| Business registration | INSMED INCORPORATED | State business registries | name and state | |
| Business registration | INSMED INCORPORATED | State business registries | name and state | |
| Form 5500 plan sponsor | INSMED INCORPRATED | EIN (EXACT) | ||
| Federal award recipient | INSMED INCORPORATED | Federal spending (USAspending) | name and state | |
| Lobbying client | INSMED, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSMED INCORPORATED | Federal lobbying (LDA) | name and state | |
| Lobbying client | INSMED INCORPORATED | Federal lobbying (LDA) | name and state | |
| Person page | Kenneth G Condon | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NJ first:
- KOS PHARMACEUTICALS INC NJ
- NOVADEL PHARMA INC NJ
- ELITE PHARMACEUTICALS INC /NV/ NJ
- MEMORY PHARMACEUTICALS CORP NJ
- PHIBRO ANIMAL HEALTH CORP NJ
- PTC THERAPEUTICS, INC. NJ
- ADVANCED NUTRACEUTICALS INC NJ
- Ayala Pharmaceuticals, Inc. NJ
- Sonnet BioTherapeutics Holdings, Inc. NJ
- WARNER CHILCOTT PLC NJ
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health